Clinical trial
Developing Medication For Tobacco Addiction: NMDA Agents
NCT00136747 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Developing Medication For Tobacco Addiction: NMDA Agents
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- May 31, 2009
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.